Role of Notified Bodies in IVD Certification: The Transition from the Directive to the Regulation
The transition from the IVDD directive to the IVDR regulation (EU) 2017/746 has radically transformed the European landscape of in vitro diagnostic medical devices, addressing the challenges of personalized medicine and the vulnerabilities exposed by the Poly Implant Prothèse (PIP) scandal, which exclusively concerned general medical devices but ultimately paved the way for the reform of both directives. This overhaul has placed Notified Bodies (NBs) at the center of the system, extending their mandatory oversight from 8% to over 80% of devices on the market through a risk-based classification. A documentary search within the EUR-Lex and NANDO registries alongside a PubMed bibliographic analysis (2017–2026) reveals a severe structural imbalance: the strict requirements of Annex VII contracted the active network to just 19 units, slowing down certification timelines. The analysis demonstrates that these delays are further compounded by new intersectoral procedures, such as mandatory EMA consultations for companion diagnostics (CDx) and review timelines by EU Reference Laboratories (EURLs) for Class D devices. The discussion of these data underscores that while the successive transitional extensions introduced first by Regulation (EU) 2022/112 and subsequently by Regulation (EU) 2024/1860 temporarily averted a lack in healthcare supplies, long-term market stability cannot rely on continuous legislative delays but demands an operational optimization of this restricted oversight network.
Authors
- Angela Candido
- Angela Costantino (ORCID: https://orcid.org/0000-0003-2897-3595)
- Federico Piras
- Veronica Mari (ORCID: https://orcid.org/0000-0001-5960-5803)
- Roberta Marcoaldi
- Daniele Maria Scarpino Schietroma
- Alessandro Ricci
Institutions
- Istituto Superiore di Sanità (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- International Journal of Medical Devices
- Published
- 2026-11-17
- DOI
- https://doi.org/10.3390/ijmd1020010
- Primary Topic
- Healthcare Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00